Late Biomarkers in Adult Survivors After Out-of-hospital Cardiac Arrest
1 other identifier
observational
400
1 country
3
Brief Summary
Blood samples are collected at six months follow-up from adult survivors after out-of-hospital cardiac arrest. Patients will be informed about the study and if they consent to participation, venous blood will be drawn by authorised medical personnel. Plasma, serum and PAX-RNA will be collected (ca 15 ml in total), processed and frozen for analysis after trial completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
June 27, 2025
June 1, 2025
3.3 years
June 18, 2024
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional outcome
Modified Rankin Scale 4-6
6 months
Secondary Outcomes (2)
Neurocognitive outcomes
6 months
Neurocognitive outcomes
6 months
Eligibility Criteria
Adult patients with an out-of-hospital cardiac arrest who survived to six months follow-up
You may qualify if:
- Survivors of out-of-cardiac arrest who participate in the extended follow-up study of the STEPCARE trial at selected sites only
You may not qualify if:
- Patients not participating in the extended follow-up at participating sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
- Lund Universitycollaborator
- University of Helsinkicollaborator
Study Sites (3)
Helsingborgs Hospital
Helsingborg, Sweden
Skåne university hospital
Lund, Sweden
Skåne University Hospital
Malmo, Sweden
Related Links
Biospecimen
Serum, plasma and PAX-RNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2024
First Posted
September 19, 2024
Study Start
October 1, 2025
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2032
Last Updated
June 27, 2025
Record last verified: 2025-06